Revvity AlphaLISA SureFire Ultra Human and Mouse Total AKT3 Detection Kit, 50,000 Assay Points

AKT3 is a serine/threonine protein kinase and a key member of the PI3K/AKT signaling pathway, playing critical roles in brain development, neuronal survival, and cellular growth regulation. AKT3 is activated by phosphorylation at Thr305 and Ser472 downstream of PI3K, promoting protein synthesis, cell survival, and glucose metabolism while regulating cell size and proliferation. It is particularly important in the central nervous system, where it controls brain size, neuronal differentiation, and synaptic plasticity. Mutations or altered expression of AKT3 are associated with microcephaly, macrocephaly, neurological disorders, and various cancers including melanoma, breast, and prostate carcinomas. In oncology, AKT3 promotes tumor cell survival, invasion, and drug resistance while supporting cancer stem cell maintenance and epithelial-to-mesenchymal transition. Therapeutic targeting of AKT3 through selective inhibitors represents a promising strategy for both neurodevelopmental disorders and aggressive cancer subtypes, particularly those with enhanced metastatic potential.

The AlphaLISA SureFire Ultra Human and Mouse Total AKT3 is a sandwich immunoassay for the quantitative detection of total AKT3 in cellular lysates, using Alpha Technology.

Formats:

• The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
• The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
• The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
• The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Ultra kits are compatible with:

• Cell and tissue lysates
• Antibody modulators
• Biotherapeutic antibodies

AlphaLISA SureFire Ultra kits can be used for:

• Cellular kinase assays
• Receptor activation studies
• High-throughput screening for preclinical studies